Drug Shortage Report for TRIESENCE
Report ID | 140457 |
Drug Identification Number | 02368676 |
Brand name | TRIESENCE |
Common or Proper name | Triesence 1mL Susp |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TRIAMCINOLONE ACETONIDE |
Strength(s) | 40MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAVITREAL INTRAVITREAL |
Packaging size | 1mL |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-10-11 |
Actual start date | 2021-10-14 |
Estimated end date | 2022-01-14 |
Actual end date | 2021-12-22 |
Shortage status | Resolved |
Updated date | 2022-01-04 |
Company comments | Production constraints limit product availability. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v23 | 2022-01-04 | French | Compare |
v22 | 2022-01-04 | English | Compare |
v21 | 2021-12-16 | French | Compare |
v20 | 2021-12-16 | English | Compare |
v19 | 2021-10-29 | French | Compare |
v18 | 2021-10-29 | English | Compare |
v17 | 2021-10-19 | French | Compare |
v16 | 2021-10-19 | English | Compare |
v15 | 2021-10-12 | French | Compare |
v14 | 2021-10-07 | French | Compare |
v13 | 2021-10-07 | English | Compare |
v12 | 2021-10-05 | English | Compare |
v11 | 2021-09-27 | French | Compare |
v10 | 2021-09-27 | English | Compare |
v9 | 2021-09-27 | English | Compare |
v8 | 2021-07-29 | French | Compare |
v7 | 2021-07-29 | English | Compare |
v6 | 2021-07-27 | English | Compare |
v5 | 2021-07-13 | French | Compare |
v4 | 2021-07-13 | English | Compare |